NISA Engagement and Impact Assessment Consultation Paper
June 2016 BioMelbourne Network welcomed the opportunity to contribute a submission in response to the National Innovation & Science Agenda (NISA) Engagement and Impact Assessment Consultation Paper. Research engagement and impact is a very important issue for BioMelbourne…
Response to Medical Technology and Pharmaceuticals Discussion Paper
September 2015 In September 2015, BioMelbourne Network welcomed the opportunity to contribute to the Medical Technology and Pharmaceuticals Discussion Paper produced by the Victorian Government’s Department of Economic Development, Jobs, Transport and Resources. This Paper formed part of…
Women in STEM and Entrepreneurship Roundtable Discussion
April 2016 In April 2016, Dr Krystal Evans participated in a roundtable discussion on “Women in STEM and Entrepreneurship” in Canberra. The aim of this roundtable was to bring together key representatives from Government, industry, research and education to…
R&D Tax Incentive Review (February 2016)
February 2016 The R&D tax incentive is a highly successful policy programme has helped many Australian biotechnology and medical technology businesses to undertake additional R&D activities and to successfully create innovative health care products for the global export…
MRFF Submission (June 2016)
June 2016 The MRFF will be used to drive medical innovation, and is a massive opportunity to boost research translation and accelerate the development of discoveries into clinical reality in Australia. The Australian Medical Research Advisory Board held…
Roundtable Discussion: The Biotech and Medtech Startup Ecosystem (June 2016)
June 2016 BioMelbourne Network in partnership with Allens hosted a roundtable with the Hon Phillip Dalidakis Minister for Small Business, Innovation and Trade on the 20th of June to discuss the biotech and medtech startup ecosystem. Minister Dalidakis…
Industry/Academia Working Group (May 2016)
May 2016 The BioMelbourne Network Industry/Academia Working group was established to work toward a shared vision for Melbourne as a city with a rich culture of collaboration that fosters industry-academic engagement. The purpose of the group is to…
Clinical/Industry Working Group May (2016)
May 2016 The BioMelbourne Network Clinical/Industry Working Group was established to work toward a shared vision for Melbourne as a world leading location for clinical trials. The purpose of the group is to promote and support Melbourne as…
